Nicholas Choong

Nicholas Choong

Company: Seattle Genetics

Job title: Executive Medical Director and Global Development Lead of the LIV-1 ADC program


Combining ADCs & Immunotherapy: Mechanistic Insights & Clinical Observations 5:00 pm

Discuss preclinical data demonstrating monomethyl auristatin E (MMAE) has the potential to drive immunogenic cell death Review pre-clinical and biomarker data on MMAE that support the induction of inflammatory cytokines and innate inflammatory responses which are consistent with MMAE-induced ICD Share insight from how our data provide the rationale for combining our ADCs with immuno-oncology…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.